Measles, Mumps, and Rubella - Centers for Disease Control and ...

48 MMWR May 22, 1998To prevent droplet transmission of the disease, respiratory isolation precautions forpersons with mumps should be maintained for 9 days after onset of symptoms (e.g.,parotitis). If exposed to mumps, health-care workers who lack acceptable evidence ofimmunity (Table 1) should be excluded from the health-care facility from the 12th dayafter the first exposure through the 26th day after the last exposure. Workers in whomthe disease develops should be excluded from work until 9 days after the onset ofsymptoms.References1. Bloch AB, Orenstein WA, Stetler HC, et al. Health impact of measles vaccination in the UnitedStates. Pediatrics 1985;76:524–32.2. Siegel M, Fuerst HT. Low birth weight and maternal virus diseases: a prospective study ofrubella, measles, mumps, chickenpox, and hepatitis. JAMA 1966;197:680–4.3. Jespersen CS, Littauer J, Sagild U. Measles as a cause of fetal defects. Acta Paediatr Scand1977;66:367–72.4. Atmar RL, Englund JA, Hammill H. Complications of measles during pregnancy. Clin InfectDis 1992;14:217–26.5. Eberhart-Phillips JE, Frederick PD, Baron RC, Mascola L. Measles in pregnancy: a descriptivestudy of 58 cases. Obstet Gynecol 1993;82:797–801.6. Markowitz LE, Chandler FW, Roldan EO, et al. Fatal measles pneumonia without rash in achild with AIDS. J Infect Dis 1988;158:480–3.7. CDC. Measles in HIV-infected children, United States. MMWR 1988;37:183–6.8. CDC. Measles surveillance report No.11, 1977–1981. September 1982; 6–89.9. CDC. Summary of notifiable diseases, United States–1993. MMWR 1993;42:67.10. CDC. Reported vaccine-preventable diseases—United States, 1993, and the Childhood ImmunizationInitiative. MMWR 1994;43:57–60.11. The National Vaccine Advisory Committee. The measles epidemic: the problems, barriers, andrecommendations. JAMA 1991;266:1547–52.12. Atkinson WL. Epidemiology and prevention of measles. Dermatol Clin 1995;13:553–9.13. CDC. Measles—United States, 1995. MMWR 1996;45:305–7.14. CDC. Status report on the Childhood Immunization Initiative: reported cases of selected vaccine-preventablediseases—United States, 1996. MMWR 1997;46:665–71.15. Pan American Health Organization. Measles elimination by the year 2000. EPI Newsletter 1994;16:1–2.16. Rota JS, Rota PA, Redd SC, Pattamadilok S, Bellini WJ. Genetic analysis of measles virusesisolated in the United States, 1995–1996. J Infect Dis 1998;177:204–8.17. Watson JC, Redd SC, Rhodes PH, Hadler SC. The interruption of transmission of indigenousmeasles in the United States during 1993. Pediatr Infect Dis J 1998;17:363–6.18. Lindegren ML, Fehrs LJ, Hadler SC, Hinman AR. Update: rubella and congenital rubella syndrome,1980–1990. Epidemiol Rev 1991;13:341–8.19. Peckham CS. Clinical and laboratory study of children exposed in utero to maternal rubella.Arch Dis Child 1972;47:571–7.20. CDC. Rubella and congenital rubella syndrome—United States, 1984–1985. MMWR 1986;35:129–35.21. Cochi SL, Edmonds LD, Dyer K, et al. Congenital rubella syndrome in the United States, 1970–1985: on the verge of elimination. Am J Epidemiol 1989;129:349–61.22. Mellinger AK, Cragan JD, Atkinson WL, et al. High incidence of congenital rubella syndromeafter a rubella outbreak. Pediatr Infect Dis J 1995;14:573–8.23. Dales LG, Chin J. Public health implications of rubella antibody levels in California. Am J PublicHealth 1982;72:167–72.24. Dales LG, Chin J. An outbreak of congenital rubella. West J Med 1981;135:266–70.25. Lamprecht C, Schauf V, Warren D, Nelson K, Northrop R, Christiansen M. An outbreak of congenitalrubella syndrome in Chicago. JAMA 1982;247:1129–33.26. Kaplan KM, Cochi SL, Edmonds LD, Zell ER, Preblud SR. A profile of mothers giving birth toinfants with congenital rubella syndrome: an assessment of risk factors. Am J Dis Child 1990;144:118–23.